ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $117,854 | -19.2% | 19,480 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $145,787 | +73.6% | 18,787 | +19.7% | 0.00% | – |
| Q1 2022 | $84,000 | -66.0% | 15,697 | -6.6% | 0.00% | -100.0% |
| Q4 2021 | $247,000 | -31.8% | 16,802 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $362,000 | +24.0% | 17,305 | +4.7% | 0.00% | +100.0% |
| Q2 2021 | $292,000 | -9.9% | 16,534 | +25.2% | 0.00% | 0.0% |
| Q1 2021 | $324,000 | -25.9% | 13,207 | +2.4% | 0.00% | -50.0% |
| Q4 2020 | $437,000 | +236.2% | 12,898 | +147.7% | 0.00% | +100.0% |
| Q3 2020 | $130,000 | -27.8% | 5,207 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $180,000 | – | 5,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |